Regenerative & Stem Cell Therapy
Personalised stem cell programmes for ALS, Multiple Sclerosis, Parkinson's, Neuropathy, Muscular Dystrophy, Autism, and more. Treatment at our Warsaw clinic or with our medical team at your location worldwide. Clinical practice since 2013.
Current Situation
For most neurodegenerative diagnoses, standard treatment slows symptoms while the disease advances. Cellular therapy targets the underlying biology — neuroinflammation, cell death, disrupted signalling — to halt functional decline where conventional medicine cannot.
Patients Treated
2,500+
across 20+ countries, continuously monitored
Stabilisation Rate
78%
functional decline halted at ≥6 months
In-House Laboratory
100%
all cell processing, testing, and verification on-site
Stabilisation means a measurable halt of functional decline on validated clinical scales — ALSFRS-R, EDSS, UPDRS, GMFCS — maintained for at least six months post-treatment.
Source: BioCells Medical Clinical Registry, 2013–2025
Treatment Programmes
Personalised stem cell therapy protocols for neurological, autoimmune, and degenerative diseases. Each programme is designed individually based on diagnosis, disease stage, and biological profile.
76%
functional stabilisation
79%
functional stabilisation
77%
functional stabilisation
69%
functional stabilisation
81%
symptom reduction
75%
functional stabilisation
78%
behavioural improvement
73%
motor improvement
To see the full list of diagnoses, visit the diagnoses page →
Our Approach
BioCells Medical is not a single procedure — it is a complete medical programme. Each protocol is designed individually, based on molecular diagnostics, biological profiling, and clinical data collected since 2013.
Our certified laboratory in Warsaw handles every step of cell preparation internally — from bone marrow harvesting to viability testing and sterility verification. No outsourcing, no shortcuts, no compromise on quality.
Cells are delivered intravenously or locally — no surgical incisions.
Autologous cells from the patient's own body where clinically possible — eliminating immune rejection.
Treatment does not disrupt daily routine. Most patients resume normal activities within days.
All procedures are performed under local anaesthesia or without anaesthesia entirely. Safe for patients of any age and condition.
Process
From initial consultation to long-term post-treatment monitoring — a structured medical programme designed around your specific condition.
Initial consultation with a medical coordinator to review your condition and medical history.
Initial consultation with a medical coordinator to review your condition and medical history.
Our team analyses your medical records, test results, and all relevant documentation.
Our team analyses your medical records, test results, and all relevant documentation.
A physician council reviews your case. You can invite your treating doctor. Full treatment programme is presented.
A physician council reviews your case. You can invite your treating doctor. Full treatment programme is presented.
Scheduling dates and coordinating logistics — whether you visit our Warsaw clinic or our medical team travels to you.
Scheduling dates and coordinating logistics — whether you visit our Warsaw clinic or our medical team travels to you.
A personalised rehabilitation programme and long-term monitoring. Every patient receives a medical wearable bracelet for continuous tracking of vital parameters.
A personalised rehabilitation programme and long-term monitoring. Every patient receives a medical wearable bracelet for continuous tracking of vital parameters.
Certified Laboratory
Every therapeutic element is produced and quality-controlled in our certified Warsaw laboratory. The exact combination, dosage, and sequencing of all five components is determined individually by our medical board for each patient.
Certified Laboratory
Every therapeutic element is produced and quality-controlled in our certified Warsaw laboratory. The exact combination, dosage, and sequencing of all five components is determined individually by our medical board for each patient.
Multipotent regenerative cells harvested from the patient's own bone marrow (approximately 50 ml under local anaesthesia) or from certified donor sources. MSCs modulate neuroinflammation, support neuron survival, protect neural structures, and activate the body's own regenerative mechanisms. This is the primary therapeutic component for most neurological diagnoses.
Multipotent regenerative cells harvested from the patient's own bone marrow (approximately 50 ml under local anaesthesia) or from certified donor sources. MSCs modulate neuroinflammation, support neuron survival, protect neural structures, and activate the body's own regenerative mechanisms. This is the primary therapeutic component for most neurological diagnoses.
Specialised immune cells responsible for maintaining immune balance. In autoimmune and neuroinflammatory conditions, T-regs suppress the excessive immune activity that damages nervous tissue. Applied in autologous or allogeneic protocols depending on the patient's immune profile and clinical indicators.
Nanoscopic biological vesicles produced by regenerative cells, containing growth factors, regulatory proteins, and micro-RNA. They work at a molecular level: reducing oxidative stress, supporting neuronal signalling, and improving metabolism in damaged tissue. Produced in-house as a high-purity concentrated preparation.
Non-invasive medical technology delivering precisely controlled electrical impulses to targeted areas of the brain and spinal cord. Used to reactivate weakened neural pathways, improve functional connectivity, and restore signal transmission between the central nervous system and peripheral muscles.
Biologically active messenger molecules that restore disrupted intercellular communication. Selected individually based on the patient's metabolic profile, neurological status, and disease stage. Applied to improve mitochondrial efficiency, protein synthesis, and regulation of chronic inflammatory processes.
Stabilisation Rate
78%
Functional decline halted at ≥6 months, measured across all diagnoses by validated scales
Time to Clinical Response
2–4 weeks
Standard time from start of therapy to first clinical improvement
Effect Duration
3.5 years
Average duration of sustained therapeutic benefit across registry follow-up data
In-House Processing
100%
Full cycle: cell isolation, cultivation, and quality control — all at our certified Warsaw laboratory
Internal registry data (2013–2025). Not results of randomised controlled trials. Individual outcomes vary.
Medical Team
A multidisciplinary team of physicians, laboratory scientists, and patient coordinators.
Medical Director
Oversees all medical programmes, ensures scientific rigour and patient safety standards.
Laboratory Chief
Manages cell cultivation and quality control in the certified Warsaw laboratory.
Leading Neurologist
Develops neuroregenerative protocols for neurological conditions.
Patient Stories
“After the treatment my husband can hold his head better and speak longer without severe fatigue. His breathing became more stable and the sudden declines we had before stopped. We saw a real slowing of the disease and that is what matters most to us.”
Patient's wife
ALS · Belgium
Patient Cases
Documented treatment outcomes recorded by the BioCells Medical team after personalised regenerative medicine protocols.
Amyotrophic Lateral Sclerosis
Parkinsonism
Chronic Obstructive Pulmonary Disease
Secondary Progressive Multiple Sclerosis (SPMS)
Get Started
Submit your case for review. No obligation. Our medical consultant will get back to you within 24 hours.
Submit your case online or by phone
Our medical consultant contacts you to review your documents
The medical board presents a personalised assessment
Request a Consultation
Tell us about your condition. Our medical consultant will contact you within 24 hours to review your documents.
Open Consultation FormGoogle Reviews
BioCells Medical — cellular therapy clinic in Warsaw. Franciszka Klimczaka 8A.
See all reviews on GoogleInside the Clinic
